NNDSS - Table II. Lyme disease to Meningococcal

NNDSS - Table II. Lyme disease to Meningococcal - 2016. In this Table, provisional* cases of selected† notifiable diseases (≥1,000 cases reported during the preceding year), and selected low frequency diseases are displayed. The Table includes total number of cases reported in the United States, by region and by states, in accordance with the current method of displaying MMWR data. Data on United States exclude counts from US territories.

Note:
These are provisional cases of selected national notifiable diseases, from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data reported by the 50 states, New York City, the District of Columbia, and the U.S. territories are collated and published weekly as numbered tables printed in the back of the Morbidity and Mortality Weekly Report (MMWR). Cases reported by state health departments to CDC for weekly publication are provisional because of ongoing revision of information and delayed reporting.

Case counts in this table are presented as they were published in the MMWR issues. Therefore, numbers listed in later MMWR weeks may reflect changes made to these counts as additional information becomes available.

Footnotes:
C.N.M.I.: Commonwealth of Northern Mariana Islands.
U: Unavailable. -: No reported cases. N: Not reportable. NN: Not Nationally Notifiable. NP: Nationally notifiable but not published. Cum: Cumulative year-to-date counts. Med: Median. Max: Maximum.

* Case counts for reporting year 2016 are provisional and subject to change. For further information on interpretation of these data, see http://wwwn.cdc.gov/nndss/document/ ProvisionalNationaNotifiableDiseasesSurveillanceData20100927.pdf. Data for TB are displayed in Table IV, which appears quarterly.
† Three low incidence conditions, rubella, rubella congenital, and tetanus, are in Table II to facilitate case count verification with reporting jurisdictions.
§ Data for meningococcal disease, invasive caused by serogroups ACWY; serogroup B; other serogroup; and unknown serogroup are available in Table I.

NNDSS - 表II. 拉姆齐病至脑膜炎奈瑟菌 - 2016。本表中展示了选定（上一年度报告病例数不少于1,000例）的应报告疾病（包括低频疾病）的临时性*病例，并按地区和州别分列。表格包含了美国各地区及各州的病例总数，按照当前《发病率和死亡率周报》（MMWR）的展示方法进行排列。美国数据不包括美属领土的统计数。

注：
这些是来自国家应报告疾病监测系统（NNDSS）的选定国家应报告疾病的临时性病例。NNDSS数据由50个州、纽约市、哥伦比亚特区以及美属领土报告，并按周汇编成编号表格，刊载在《发病率和死亡率周报》（MMWR）的背面。向CDC报告以供每周发布的病例数为临时性，因为这些数据仍在修订中，且存在延迟报告的情况。

表格中的病例数按《发病率和死亡率周报》的发布情况呈现。因此，在后续的MMWR周报中列出的数字可能会随着新信息的出现而对这些数字进行修改。

脚注：
C.N.M.I.：北马里亚纳群岛联邦。
U：不可用。
-：无报告病例。
N：不可报告。
NN：非国家应报告。
NP：国家应报告但未发布。
Cum：累计至当年至今数。
Med：中位数。
Max：最大值。

*2016年报告的病例数为临时性，可能发生变化。有关这些数据的解释，请参阅http://wwwn.cdc.gov/nndss/document/ProvisionalNationaNotifiableDiseasesSurveillanceData20100927.pdf。结核病数据在表IV中展示，该表按季度发布。
†为便于与报告辖区进行病例计数验证，表II中包含了三种低发病率状况：风疹、先天性风疹和破伤风。
§脑膜炎奈瑟菌病数据，包括由ACWY血清群、B血清群、其他血清群和未知血清群引起的侵袭性疾病，可在表I中找到。